Related Experiment Videos
The dosimetry of brachytherapy-induced erectile dysfunction
Gregory S Merrick1, Wayne M Butler
1Schiffler Cancer Center, Wheeling Hospital, 1 Medical Park, Wheeling, WV 26003-6300, USA.
Summary
Brachytherapy-induced erectile dysfunction (ED) may be reduced by optimizing radiation dose to the proximal penis. Careful technique and seed placement are key to preserving potency after prostate brachytherapy.
Area of Science:
- Oncology
- Radiation Oncology
- Urology
Background:
- Brachytherapy is a common treatment for prostate cancer.
- Erectile dysfunction (ED) is a potential side effect of brachytherapy.
- The specific structures responsible for ED after brachytherapy are not fully understood.
Purpose of the Study:
- To review the relationship between radiation dose and brachytherapy-induced ED.
- To identify critical structures for potency preservation during prostate brachytherapy.
Main Methods:
- Systematic review of the permanent prostate brachytherapy literature using MEDLINE.
- Analysis of dosimetry data related to radiation exposure of the prostate and surrounding structures.
Main Results:
- The proximal penis is implicated as a critical structure in brachytherapy-induced ED.
- Maintaining specific radiation doses to the penile bulb (D50 < 40% mPD, D25 < 60% mPD) and crura (D50 < 28% mPD) may maximize post-treatment potency.
- No association found between ED and radiation dose to neurovascular bundles or isotope choice.
Conclusions:
- Brachytherapy-induced ED is likely multifactorial but influenced by technique.
- Optimizing implant technique and seed placement to reduce radiation dose to the proximal penis may improve potency preservation.